Jarmo Oksi

3.3k total citations
68 papers, 1.7k citations indexed

About

Jarmo Oksi is a scholar working on Infectious Diseases, Parasitology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jarmo Oksi has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 32 papers in Parasitology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jarmo Oksi's work include Vector-borne infectious diseases (31 papers), Viral Infections and Vectors (25 papers) and Streptococcal Infections and Treatments (11 papers). Jarmo Oksi is often cited by papers focused on Vector-borne infectious diseases (31 papers), Viral Infections and Vectors (25 papers) and Streptococcal Infections and Treatments (11 papers). Jarmo Oksi collaborates with scholars based in Finland, United States and Czechia. Jarmo Oksi's co-authors include Matti K. Viljanen, Uga Dumpis, Derrick W. Crook, Jukka Hytönen, J Nikoskelainen, Ilkka Seppälä, Ulla Hohenthal, Merja Marjamäki, Qiushui He and Tero Heikkilä and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Jarmo Oksi

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jarmo Oksi Finland 24 1.2k 957 500 337 211 68 1.7k
Tommaso Furlanello Italy 28 822 0.7× 914 1.0× 578 1.2× 373 1.1× 316 1.5× 91 2.0k
B. Jaulhac France 25 1.5k 1.2× 1.7k 1.7× 489 1.0× 318 0.9× 490 2.3× 103 2.4k
Mathios E. Mylonakis Greece 24 764 0.6× 875 0.9× 586 1.2× 369 1.1× 239 1.1× 87 1.8k
Cléa Melenotte France 18 933 0.8× 869 0.9× 336 0.7× 313 0.9× 282 1.3× 57 1.7k
Andrew L. Leisewitz South Africa 22 897 0.7× 863 0.9× 267 0.5× 192 0.6× 336 1.6× 79 1.8k
Leif Dotevall Sweden 20 797 0.6× 639 0.7× 205 0.4× 289 0.9× 117 0.6× 44 1.3k
Clarisse Rovery France 18 886 0.7× 592 0.6× 587 1.2× 438 1.3× 178 0.8× 30 1.4k
Kasi Russell‐Lodrigue United States 24 1.2k 1.0× 510 0.5× 343 0.7× 629 1.9× 101 0.5× 56 1.9k
Amy M. Denison United States 18 688 0.6× 455 0.5× 218 0.4× 326 1.0× 93 0.4× 30 1.2k
Claudia Colomba Italy 26 1.1k 0.9× 416 0.4× 541 1.1× 447 1.3× 88 0.4× 143 2.1k

Countries citing papers authored by Jarmo Oksi

Since Specialization
Citations

This map shows the geographic impact of Jarmo Oksi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarmo Oksi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarmo Oksi more than expected).

Fields of papers citing papers by Jarmo Oksi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarmo Oksi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarmo Oksi. The network helps show where Jarmo Oksi may publish in the future.

Co-authorship network of co-authors of Jarmo Oksi

This figure shows the co-authorship network connecting the top 25 collaborators of Jarmo Oksi. A scholar is included among the top collaborators of Jarmo Oksi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarmo Oksi. Jarmo Oksi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palomäki, Antti, et al.. (2024). Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy. European Journal of Clinical Microbiology & Infectious Diseases. 43(4). 723–734. 3 indexed citations
2.
Oksi, Jarmo, Jussi Jero, Eliisa Löyttyniemi, et al.. (2024). Glioma grade and post-neurosurgical meningitis risk. Acta Neurochirurgica. 166(1). 300–300. 1 indexed citations
3.
Anttalainen, Ulla, Maritta Kilpeläinen, Ulla Hohenthal, et al.. (2023). Rapid implementation of home oxygen treatment and remote monitoring for COVID-19 patients at the verge of the Omicron wave in Turku, Finland. BMC Infectious Diseases. 23(1). 799–799. 1 indexed citations
4.
Löyttyniemi, Eliisa, et al.. (2023). Bacterial meningitis in adults: a retrospective study among 148 patients in an 8-year period in a university hospital, Finland. BMC Infectious Diseases. 23(1). 45–45. 10 indexed citations
5.
Toivonen, Anne, Nathalie Friberg, Timo Hautala, et al.. (2021). Clinical characteristics and evaluation of the incidence of cryptococcosis in Finland 2004–2018. Infectious Diseases. 53(9). 684–690. 5 indexed citations
6.
Oksi, Jarmo, et al.. (2021). Short- and long-term outcomes of infective endocarditis admission in adults: A population-based registry study in Finland. PLoS ONE. 16(7). e0254553–e0254553. 12 indexed citations
7.
Feuth, Thijs, Tarja Saaresranta, Antti Karlsson, et al.. (2020). Is sleep apnea a risk factor for Covid-19? findings from a retrospective cohort study. 4(3). 8 indexed citations
8.
Broman, Niklas, Thijs Feuth, M. Valtonen, et al.. (2020). IL-6 and other biomarkers as predictors of severity in COVID-19. Annals of Medicine. 53(1). 410–412. 74 indexed citations
9.
Vuopio, Jaana, et al.. (2020). Group A streptococcal bacteremias in Southwest Finland 2007–2018: epidemiology and role of infectious diseases consultation in antibiotic treatment selection. European Journal of Clinical Microbiology & Infectious Diseases. 39(7). 1339–1348. 12 indexed citations
10.
Kortela, Elisa, Mari Kanerva, Satu Kurkela, Jarmo Oksi, & Asko Järvinen. (2020). Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have?. Clinical Microbiology and Infection. 27(7). 1022–1028. 10 indexed citations
11.
Oksi, Jarmo, et al.. (2019). Treatment ofClostridioides (Clostridium) difficileinfection. Annals of Medicine. 52(1-2). 12–20. 44 indexed citations
12.
Oksi, Jarmo, et al.. (2019). Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland. European Journal of Clinical Microbiology & Infectious Diseases. 38(10). 1947–1952. 30 indexed citations
13.
Oksi, Jarmo, et al.. (2019). Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland. BMJ Open. 9(4). e026811–e026811. 49 indexed citations
14.
Oksi, Jarmo, et al.. (2018). Point-of-care testing for CXCL13 in Lyme neuroborreliosis. Diagnostic Microbiology and Infectious Disease. 91(3). 226–228. 14 indexed citations
15.
Saraste, Antti, Jukka Kemppainen, Jeroen J. Bax, et al.. (2015). 18F-FDG positron emission tomography/computed tomography in infective endocarditis. Journal of Nuclear Cardiology. 24(1). 195–206. 52 indexed citations
16.
Oksi, Jarmo, et al.. (2013). Candida dubliniensis spondylodiscitis in an immunocompetent patient. Case report and review of the literature. Medical Mycology Case Reports. 3. 4–7. 16 indexed citations
17.
Oksi, Jarmo, J Nikoskelainen, Heikki Hiekkanen, et al.. (2007). Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. European Journal of Clinical Microbiology & Infectious Diseases. 26(8). 571–581. 75 indexed citations
18.
Dumpis, Uga, Derrick W. Crook, & Jarmo Oksi. (1999). Tick‐Borne Encephalitis. Clinical Infectious Diseases. 28(4). 882–890. 259 indexed citations
19.
Oksi, Jarmo, J Nikoskelainen, & Matti K. Viljanen. (1998). Comparison of Oral Cefixime and Intravenous Ceftriaxone followed by Oral Amoxicillin in Disseminated Lyme Borreliosis. European Journal of Clinical Microbiology & Infectious Diseases. 17(10). 715–719. 29 indexed citations
20.
Oksi, Jarmo, Jussi Mertsola, Mauri Reunanen, Merja Marjamäki, & Matti K. Viljanen. (1994). Subacute Multiple-Site Osteomyelitis Caused by Borrelia burgdorferi. Clinical Infectious Diseases. 19(5). 891–896. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tommaso Furlanello Breakdown of academic impact, for papers by B. Jaulhac Breakdown of academic impact, for papers by Mathios E. Mylonakis Breakdown of academic impact, for papers by Cléa Melenotte Breakdown of academic impact, for papers by Andrew L. Leisewitz Breakdown of academic impact, for papers by Leif Dotevall Breakdown of academic impact, for papers by Clarisse Rovery Breakdown of academic impact, for papers by Kasi Russell‐Lodrigue Breakdown of academic impact, for papers by Amy M. Denison Breakdown of academic impact, for papers by Claudia Colomba
Rankless by CCL
2026